Outset Medical, Inc.

NASDAQ:OM

Medical - Devices

Healthcare
$3.04 +18.16%

+$0.73 today

Market cap
$57.31M
Beta
1.94
P/E (TTM)
-1.2
EPS (TTM)
-$4.07
52W Low $3.00High $21.36

Volume 0.05M

Average 0.16M

OM Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Outset Medical, Inc.NASDAQ: OM

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables turns positive

Q1 FY2026 accounts receivables was $3.41M, compared with -$1.47M a year earlier. Trailing-twelve-month accounts receivables was $8.65M.

Context

  • Accounts receivables amounted to 3.2% of revenue in FY2025, down 1.2 pp from a year earlier.
  • Accounts receivables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts receivables holds near $3.41M or moves back toward the trailing-twelve-month quarterly average of $2.16M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.41M+92.8% QoQ
Last fiscal yearDec 2025
$3.78M+175.3% YoY
LTMMar 2026
$8.65M+7764.5% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+332.4%——
1 year+175.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
3.78M USD
Year-over-year change
+175.3%

Accounts Receivables vs competitors

How OM compares with its peers on the latest reported figures

  • OM's LTM Mar 2026 accounts receivables of $8.65M is the 4th largest of the 10 companies compared; the peer median is $2.34M.
  • Its year-over-year change of +7764.5% is the highest of 8, against a peer median of +32.8%.
  • Accounts receivables amounts to 7.4% of revenue for OM, versus a peer median of 5.3%.
OM Competitors Peer median
Accounts Receivables for OM and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INGNInogen, Inc.LTM Mar 2026$11.95M -5.6%-34.3%3.4%
TNYATenaya Therapeutics, Inc.LTM Mar 2026$10.63M ——4723.1%
QTRXQuanterix CorporationLTM Mar 2026$9M +948.6%+27.2%6.2%
OMOutset Medical, Inc.LTM Mar 2026$8.65M +7764.5%—7.4%
SIShoulder Innovations, Inc.LTM Mar 2026$4.23M ——7.8%
VMDViemed Healthcare, Inc.LTM Mar 2026$2.56M +32.8%—0.9%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$2.34M +94.0%+9.5%5.3%
CATXPerspective Therapeutics, Inc.LTM Mar 2026$440K -119.2%—71.2%
HSDTSolana CompanyLTM Mar 2026$133K -337.5%—1.4%
NNOXNano-X Imaging Ltd.LTM Dec 2025$113.84K +135.5%+13.1%0.9%
Peer median (excluding OM) $2.34M+32.8%+11.3%5.3%

Competitors are the stored peer set for OM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(131.94M)(162.96M)(172.8M)(127.98M)(81.65M)
Depreciation & Amortization5.16M5.17M5.81M5.73M4.34M
Deferred Income Tax3.08M0000
Stock-Based Compensation17.45M27.2M38.63M29.36M15.62M
Change in Working Capital(25.6M)(21.14M)(773K)(25.69M)2.2M
Accounts Receivables(19.14M)(2.51M)(5.09M)(5.01M)3.78M
Inventory(22.04M)(14.73M)1.65M(10.86M)11.79M
Accounts Payables(3.07M)(1.28M)5.31M(1.95M)(3.29M)
Other Working Capital18.64M(2.63M)(2.64M)(7.87M)(10.08M)
Other Non-Cash Items1.59M6M(2.25M)2.28M13.17M
Operating Cash Flow(130.26M)(145.73M)(131.37M)(116.3M)(46.33M)
Capital Expenditures(3.11M)(8.33M)(3.44M)(912K)(798K)
Acquisitions (Net)139.4M57.97M000
Purchases of Investments(178.43M)(261.15M)(172.28M)(156.58M)(221.97M)
Sales of Investments39.03M203.18M258.75M261.43M125.08M
Other Investing Activities(139.4M)(57.97M)000
Investing Cash Flow(142.51M)(66.3M)83.03M103.94M(97.68M)
Debt Repayment064.86M33.23M66.52M(106.68M)
Common Stock Issued149.09M8.04M10.43M2.28M162.19M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities11.06M00(938K)0
Financing Cash Flow160.15M72.9M43.65M67.87M55.5M
Effect of Forex Changes00000
Net Change in Cash(112.62M)(139.13M)(4.7M)55.51M(88.51M)
Free Cash Flow(133.37M)(154.05M)(134.81M)(117.22M)(47.13M)

Outset Medical, Inc.

NASDAQ:OM

Intrinsic Alpha fair value

Locked

Current Price

$3.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.